NCS Healthcare of Kentucky recalls
NCS Healthcare of Kentucky has 3 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 29 Nov 2023. The most frequent reason is packaging defects.
Total recalls3since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 Nov 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 33%Class III 2 67%
Why ncs healthcare of kentucky is recalled
Product types
By year
All ncs healthcare of kentucky recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Buspirone Hydrochloride Tabs USP 10 mg recalledBuspirone Hydrochloride | NCS Healthcare of Kentucky | Packaging Defects | Nationwide |
| Drug | CLASS III | Lisinopril Tablets USP 20 mg recalled by NCS Healthcare of KentuckyBuspirone Hydrochloride | NCS Healthcare of Kentucky | Packaging Defects | Nationwide |
| Drug | CLASS II | Glycopyrrolate Tabs, USP, 1 mg unit dose blister card recalled | NCS Healthcare of Kentucky | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.